This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03928/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03928/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03928/identifier/pubchem-substance/
n14http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB03928/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03928/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03928
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB03928 n14:DB03928
dcterms:title
Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol
adms:identifier
n7:46507497 n8:CCO n9:446195 n10:393615 n13:DB03928
n3:IUPAC-Name
n4:271B508C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5092-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5091-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B508E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B508F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5090-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B508A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B508B-363D-11E5-9242-09173F13E4C5 n4:271B5088-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5089-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5098-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5099-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5093-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5094-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5096-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5095-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5097-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B509E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B50A0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B50A1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B509D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B509C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B509F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B508D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B509A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B509B-363D-11E5-9242-09173F13E4C5